Twinlab Consolidated (TLCC) Stock Price, News & Analysis

Company Overview

Twinlab Consolidated Corp. is a U.S.-based manufacturer and marketer of nutritional supplements and wellness products, trading on the OTC Markets under the ticker TLCC. The company’s portfolio includes a broad array of vitamins, minerals, herbal extracts, amino acids, protein powders, omega-3 fatty acids and specialty formulations designed to support general health, sports nutrition, weight management and beauty applications. Twinlab markets these products under its flagship brand while also providing private label and contract manufacturing services to retailers and health professionals.

Founded in 1968 by Bill and Betty Milner as a small vitamin repackaging operation in New York, Twinlab has grown into an integrated supplier with in-house research, development, manufacturing and distribution capabilities. Headquartered in Boca Raton, Florida, the company operates FDA-registered, cGMP-compliant facilities and invests in rigorous quality control, analytical testing and product innovation to ensure that its formulations meet the highest standards for safety and efficacy.

While Twinlab’s primary market remains the United States, the company exports select products to distributors across Europe, Asia and Latin America. Its sales channels encompass specialty and natural food retailers, pharmacies, fitness centers and e-commerce platforms. Through its contract manufacturing division, Twinlab offers turnkey solutions for domestic and international wellness brands seeking product formulation, packaging and regulatory support.

Twinlab Consolidated is led by a seasoned executive team with decades of experience in nutritional sciences, consumer marketing and supply-chain management. The company continues to pursue growth through targeted investments in emerging wellness categories, new product launches driven by scientific research and strategic partnerships that expand its distribution footprint and strengthen brand equity.

Key Stats

• Today's Range: $0.0005 to $0.0005
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.03
• Volume: N/A
• Average Volume: 31,720 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TLCC Stock Analysis - Frequently Asked Questions

How have TLCC shares performed this year?

Twinlab Consolidated's stock was trading at $0.0011 at the start of the year. Since then, TLCC shares have decreased by 53.3% and is now trading at $0.0005.

How do I buy shares of Twinlab Consolidated?

Shares of TLCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Twinlab Consolidated own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Twinlab Consolidated investors own include CVS Health (CVS), CubeSmart (CUBE), Cisco Systems (CSCO), CRISPR Therapeutics (CRSP), Cameco (CCJ), Blackstone Mortgage Trust (BXMT) and Boeing (BA).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:TLCC
• CIK: 1590695
• Web: www.tchhome.com
• Phone: (561) 443-4301
• Fax: N/A
• Employees: 60
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A